首页 正文

A CRISPR-Cas13d cancer therapeutic enables selective elimination of uveal melanoma

{{output}}
Uveal melanoma, the most common eye cancer in adults, remains limited to surgical intervention and radiotherapy, with a dismal survival rate that has not improved in over 50 years. To address this therapeutic impasse, we systematically analyzed public gene exp... ...